HOWL - Werewolf Therapeutics GAAP EPS of -$0.39 revenue of $0.74M May, 03 2024 07:34 AM Werewolf Therapeutics Inc. 2024-05-03 07:34:15 ET More on Werewolf Therapeutics Werewolf Therapeutics: In The Hunt For Success In The Cytokine Space Seeking Alpha’s Quant Rating on Werewolf Therapeutics Historical earnings data for Werewolf Therapeutics Financial information for Werewolf Therapeutics For further details see: Werewolf Therapeutics GAAP EPS of -$0.39, revenue of $0.74M